Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2

Conditions

Arthritis, Rheumatoid 8Psoriasis 7Lymphoma, Follicular 4Leukemia 4Myelodysplastic Syndromes 3Asthma 3Vasculitis 2Respiratory Distress Syndrome 2Recurrence 2Pneumonia 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Inflammation 2Granulomatosis with Polyangiitis 2Bronchiolitis Obliterans 2Arthritis, Psoriatic 2Arthritis, Juvenile 2Wilms Tumor 1Uveitis 1Temporomandibular Joint Disorders 1Spondylitis, Ankylosing 1Spondylarthritis 1Pruritus 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Plaque, Amyloid 1Pancreatic Neoplasms 1Neuroblastoma 1Neoplasms 1Metabolic Syndrome 1

Interventions

Cyclophosphamide 29fludarabine phosphate 27Peripheral Blood Stem Cell Transplantation 23Busulfan 23Antilymphocyte Serum 19Tacrolimus 18Radiotherapy 16Methotrexate 16Filgrastim 15Etoposide 14Mycophenolic Acid 12Cyclosporine 12Whole-Body Irradiation 11Methylprednisolone 11Melphalan 11Cytarabine 10Psychiatric Rehabilitation 9sargramostim 6Therapeutics 6Cord Blood Stem Cell Transplantation 6Flow Cytometry 5Alemtuzumab 5Thiotepa 4Thalidomide 4Sirolimus 4Early Intervention, Educational 4Cyclosporins 4thymoglobulin 3aldesleukin 3Tretinoin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × Etanercept × Clear all
NCT00093366 2011-11-30

Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes

Fred Hutchinson Cancer Center

Phase 1/2 Completed
32 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00217386 2010-09-15

Anti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic Syndromes

Fred Hutchinson Cancer Center

Phase 2 Completed
30 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡